To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With Type 2 Diabetes Mellitus
Status:
Recruiting
Trial end date:
2025-08-01
Target enrollment:
Participant gender:
Summary
A multicenter, randomized, double-blind, placebo-controlled, parallel, phase Ⅲ study to
evaluate the efficacy and safety of JW0201 added on in patients with type 2 diabetes mellitus
who have inadequate glycemic control with C2202 and C2203